With nearly 15 years of experience, Emily Goodlander represents clients in product liability and mass tort litigation matters for the life sciences sector. She has played an instrumental role in defending major pharmaceutical and vaccine manufacturers against personal injury claims in state and federal courts. Emily thrives on leveraging her background in bioethics to translate complex scientific concepts for legal purposes. She has also coordinated a multi-million-dollar budget for nationwide pharmaceutical litigation.
Well versed in the discovery process, Emily has experience performing company document review in connection with deposition preparation and document production. She has developed document review protocols, managed discovery workflows, prepared privilege logs and drafted litigation chronologies. Recently, Emily managed the discovery process in multi-district litigation and state-coordinated proceedings involving over 2,000 plaintiffs bringing personal injury claims related to a vaccine.
Emily regularly supports trial teams, contributes to strategic legal research, and collaborates closely with attorneys in high-exposure matters. She has scoured hundreds of scientific publications, drafting fact sheets and memoranda explaining their findings and identifying relevant criticism.
Trial teams look to Emily for her creativity in problem solving and attention to detail. She has supported senior attorneys in all stages of motions practice, including motions in limine, motions for summary judgment, Daubert motions and trial briefs. Notably, Emily served as primary author of a successful appellate brief on behalf of three global vaccine manufacturers.
Community is important to Emily; she offers pro bono legal services through a social justice organization providing legal assistance for LGBTQ+ clients. She’s a strong supporter of autism advocacy and domestic violence awareness organizations. Her knack for complex thinking led to an appearance on Jeopardy in 2014.